跳到正文
原文
Endpoints News 生物医药· Anna Brown·· 2026-10-05AI 评分47

Sensible Bio完成4700万美元A轮融资用于mRNA治疗制造平台

Sensible Bio secures $47M Series A for mRNA therapy manufacturing platform

AI 导读

Sensible Biotech完成4700万美元A轮融资,用于支持其mRNA治疗制造平台。

正文

Sen­si­ble Biotech­nolo­gies is look­ing to mark its ter­ri­to­ry in the in­creas­ing­ly hot space of mR­NA ther­a­peu­tics, rais­ing $47 mil­lion in a Se­ries A round to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news